# Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels

> **NCT00944073** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 583 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A

## Key facts

- **NCT ID:** NCT00944073
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 583 (ACTUAL)
- **Last updated:** 2015-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944073, "Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00944073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*